Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives $8.24 Average Price Target from Analysts
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been assigned a consensus recommendation of “Hold” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average […]
Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have been assigned a consensus recommendation of “Hold” from the nine analysts that are presently covering the firm, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average […]
